CDMO Services

There is a growing demand for oligonucleotides as medicaments and other uses due to their broad spectrum.

Technology at the service of Health

Through science and innovative medicine, Sylentis intends to become one of the main companies specialized in the discovery, development and manufacture of products based on RNAi technology for the treatment of diseases with great social impact.

Our ambition is to become the company in the sector that is most highly valued by patients, healthcare professionals, collaborators, institutional and community representatives. At Sylentis, we aspire to increase our competitiveness as a pharmaceutical company by promoting the therapeutic areas in which we research and develop medicines. Our goal is to ensure our responsiveness to unmet needs in the treatment of the disease.

Our values